Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol >=190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry [Original Articles]

Conclusions: Evidence-based LLT use remains low among patients with elevated LDL-C with significant variation in care. System-level interventions are needed to address these gaps and reduce variation in care of these high-risk patients.
Source: Circulation: Cardiovascular Quality and Outcomes - Category: Cardiology Authors: Tags: Lipids and Cholesterol, Cardiovascular Disease, Quality and Outcomes Original Articles Source Type: research